CIK 0001018735
- Accelerated filer
NYMOX PHARMACEUTICAL CORP
Sign in to watch- Ticker
- NYMXF
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Entity type
- Other
- Phone
- +1 800-936-9669
- Business address
- 9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-26 | Robinson James George Director | Purchase | +10,000 | $2.05 | $21K | 2,207,550 |
| 2015-08-24 | Robinson James George Director | Purchase | +10,000 | $2.15 | $22K | 2,197,550 |
| 2015-08-21 | Robinson James George Director | Purchase | +10,000 | $2.19 | $22K | 2,177,550 |
| 2015-08-21 | Robinson James George Director | Purchase | +10,000 | $2.10 | $21K | 2,187,550 |
Page 20 of 20 · 384 trades